Overview
- 15 inspections across 15 sites are on record.
- 16 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-05-03.
At a glance
Inspections
15
Sites
15
Observations
16
Career since
Jul 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Applied Therapeutics, Inc. | 3 May 2024 | Human Drugs | View 483 → |
| Han C. Phan, M.D. | 5 Apr 2024 | Human Drugs | View 483 → |
| Utility Therapeutics, LTD | 2 Feb 2024 | Human Drugs | On file |
| Stephen G. Kaler, M.D. | 14 Jun 2022 | Human Drugs | View 483 → |
| Vicky Malengera, M.D. | 14 Aug 2020 | Human Drugs |
Sites inspected
Applied Therapeutics, Inc.New York, United States1 insp.
Han C. Phan, M.D.Brookhaven, United States1 insp.
Utility Therapeutics, LTDAltrincham, United Kingdom1 insp.
Stephen G. Kaler, M.D.Columbus, United States1 insp.
Vicky Malengera, M.D.Butembo, Congo (Brazzaville)1 insp.
Co-investigators
Investigators who share inspections with this person.
John Dan5 shared
David L Chon5 shared
Young M Yoon5 shared
Melanie N Daniels5 shared
Ann B Borromeo2 shared
Geoffrey K Kilili2 shared
Kassa Ayalew2 shared
Kerun Hardeo1 shared
Craig A Garmendia1 shared
Benton M Ketron1 shared
Full investigator report
Get the verbatim findings behind Cheryl A Grandinetti's 16 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site